Abstract
Polyarteritis nodosa (PAN) is a medium-vessel vasculitis presenting with cutaneous and multisystem involvement with considerable morbidity. The necrotizing vasculitis in PAN typically involves renal, celiac, and mesenteric vascular beds. Coronary artery involvement is a characteristic feature of Kawasaki disease, another medium-vessel vasculitis; however, it has been rarely reported with PAN. Here, we present 2 cases with PAN involving coronaries mimicking Kawasaki disease. A 3.5-year-old boy with classical features of Kawasaki disease with giant coronary aneurysm refractory to IVIg, methylprednisolone, infliximab presented with persistent rise in inflammatory markers and gastrointestinal bleeding. Digital subtraction angiography (DSA) revealed celiac artery branches stenosis and beading suggestive of PAN. Another 2-year-old girl presented with persistent fever, abdominal pain, and distension. She had hypertension, hepatomegaly, and splenomegaly on examination. Echocardiography revealed multiple coronary aneurysms and DSA revealed numerous renal artery aneurysms. Coronary aneurysm although is a rare presentation of childhood PAN, and can mimic Kawasaki disease. Although both are medium-vessel vasculitis differentiation between these two entities is pivotal, as there are differences in treatment modalities, duration of immunomodulatory therapy, and the outcome. This manuscript describes the salient differences which can help differentiate PAN masquerading as Kawasaki disease at initial presentation.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Polyarteritis nodosa (PAN) is a systemic vasculitis chiefly affecting medium vessels. Coronary involvement in childhood PAN has rarely been reported. Unlike Kawasaki disease, the predilection for coronary involvement is rare in PAN. However, at times the distinction between two vasculitides may be challenging, particularly at the onset, which has a bearing on the therapeutic plan and long-term outcome.
Case report
Case 1 A three and half-year-old boy had a history of fever for 1 month, maculopapular rash over the trunk, periungual peeling, non-exudative conjunctivitis, and cheilitis. The child was diagnosed with Kawasaki disease and managed with oral steroids and low-dose aspirin for around a week with a transient resolution of symptoms. After 15 days, the child presented with chest pain, abdominal pain, fever, similar rash, and non-exudative conjunctivitis. The ECG was suggestive of inferior wall ischemia (Q wave in the lead 2, 3, and aVF). 2D echocardiography showed giant coronary aneurysms/dilations with the left main coronary artery (LMCA), left circumflex artery (LCx), and left anterior descending (LAD) measuring 7.1 mm (13 z score), 5.6 mm (11 z score), and 2.9 mm (2.5 z score), respectively, and right coronary artery (RCA) 2.7 mm (2.4 z score). The left ventricular ejection fraction (LVEF) was 45–50%. Inflammatory markers (CRP 187 mg/L and ESR 35 mmHg) were elevated. Kawasaki disease was diagnosed, and the child was treated with IVIg 2 g/kg, low-dose aspirin and low-molecular weight heparin (LMWH). The child continued to have fever and raised inflammatory markers (CRP 239 mg/L; ESR 48) with deteriorating cardiac function (EF 25–30%). The child was started on steroids, decongestive measures, and transiently required dobutamine support with the resolution of symptoms. He was discharged on oral steroids with tapering, oral enalapril, aspirin, and warfarin with a targeted INR of 2–3. After two months of asymptomatic period, the child presented with fever, blood in stools with persistently elevated inflammatory markers (CRP 170 mg/l and ESR 55), and echocardiogram showing increased coronary sizes (LMCA 15 z and LCx 12 z with dilated LAD 2.5 z and RCA 2.4 z). The child was treated with IV methylprednisolone 30 mg/kg in three pulses with symptom resolution. But the child had persistently elevated inflammatory markers with increasing coronary sizes, and hence a single dose of infliximab was also administered. Following this, a decline in CRP (CRP 2.3 mg/l) was observed, and he was discharged on tapering steroids, aspirin, warfarin, along with enalapril, and spironolactone. However, on tapering steroids, there was a resurgence in the levels of CRP. With GI bleed in the background with persistent increased coronary sizes and inflammatory markers, digital subtraction angiography (DSA) was performed, which showed stenosis and beading in branches of celiac arteries (Fig. 3a). Considering a long disease course of months with the elevation of inflammatory markers on weaning steroids and the characteristic DSA findings, the diagnosis was revised to PAN with the giant coronary aneurysm. The child was treated with cyclophosphamide pulse with a plan of six each monthly pulse followed by mycophenolate mofetil (MMF). The child has completed four cycles of cyclophosphamide and is doing well without recurrence of symptoms and normal inflammatory markers. Repeat echocardiography shows a decrease in the dimensions of the coronary arteries.
Case 2 A two-year-old girl presented with fever and abdominal pain for three months. The child had received multiple antibiotics for a presumed infection without any response. Echocardiography done as a part of the workup for persistent fever revealed multiple coronary artery aneurysms following which a diagnosis of Kawasaki disease was offered, and she received intravenous immunoglobulin (IVIG). However, because of persistent fever, she was referred to our center. Physical examination revealed pallor, stage I hypertension and hepato-splenomegaly (liver span of 9 cm with spleen palpable 3 cm below left costal margin). The rest of the systemic examination was unremarkable.
Investigations revealed anemia (Hemoglobin of 7 gm/dl), neutrophilic leukocytosis (total leucocyte count of TLC 26,000/mm3 with neutrophil 80%), thrombocytosis (platelet count 6.6 lakh/mm3) and raised inflammatory markers (CRP 30 mg/dl and ESR 40 mm 1st hour). The echocardiography revealed multiple coronary aneurysms (Figs. 1, 2).
In view of persistent fever, abdominal pain, and hypertension, the possibility of polyarteritis nodosa was considered, which was supported by DSA, which revealed multiple aneurysms in bilateral renal arteries (Fig. 3b). Contrast-enhanced computed tomography (CT) of the abdomen revealed multiple vasculitic infarcts involving bilateral kidneys and spleen.
She was managed with three doses of methylprednisolone 30 mg/kg/day followed by oral steroids and monthly intravenous cyclophosphamide at 500 mg/m2 planned for six months. Hypertension was managed with amlodipine and enalapril. The child has completed six cycles of cyclophosphamide and is doing well with no recurrence of symptoms. Currently, child is on oral MMF. Steroids were tapered and stopped. Repeat echocardiography shows a decrease in the dimensions of the coronary arteries.
Search strategy
We searched PubMed/Medline and Google scholar for articles with key words “Kawasaki versus Polyarteritis Nodosa”, “Coronary involvement Polyarteritis Nodosa/ PAN”, “Coronary involvement rheumatological diseases in children” the articles were carefully reviewed by first authors. We excluded articles in language other than English, irrelevant articles, and duplicates. Relevant articles to the topic of our discussion are included in literature review.
Discussion
These cases illustrate a rare clinical manifestation of childhood PAN in the form of coronary aneurysm, which is more frequently associated with Kawasaki disease (KD), leading to a diagnostic and therapeutic dilemma. Although both PAN and Kawasaki are medium-vessel vasculitis, usually with distinct clinical presentation, rarely can PAN have KD-like features as in our case 1.
Kawasaki disease, predominating in the toddler age group, presents with mucocutaneous rash and fever of acute onset along with or without coronary aneurysm [1, 2]. In contrast, the spectrum of organ involvement in PAN is wider, with a chronic course predominantly affecting school-age children and more widespread multisystem involvement in the form of hypertension, neuropathy, purpura or gangrene of skin, retinal vasculitis, aneurysm, and infarct in various sites like liver, spleen, gastrointestinal tract, and kidney [3,4,5].
The presence of coronary aneurysm is an atypical finding in PAN which, though rare, has been described in the literature. Histopathology performed post-mortem in adults with polyarteritis nodosa has demonstrated evidence of cardiac involvement with coronary arteritis found in 18/36 cases of necrotizing vasculitis on autopsy [6]. However, only a few reports of childhood PAN with coronary involvement exist. Our case 2 had a chronic course with fever and abdominal pain for three months with hepato-splenomegaly, hypertension, and showed wedge-shaped infarcts in the kidney and spleen. The child met the EULAR/PRINTO/PRES 2010 classification criteria of childhood PAN established by [7]. Bowyer and coworkers presented two such cases in 1994 where the children had aneurysms in the coronary as well as in hepatic or renal vessels [8]. Munro and coworkers recently described a 3-month-old boy who had bloody diarrhea, fever, vomiting, a very high C-reactive protein, leukocytosis, and thrombocytosis [9], in whom, on autopsy, a generalized pan arteritis was revealed, including the coronary, renal, and mesenteric arteries, consistent with diagnosis of PAN. Canares and coworkers presented a case of a 16-year-old girl with PAN and coronary aneurysm who was successfully treated with pulse cyclophosphamide therapy [10]. Yamazaki-nakashimada and coworkers [11] reported a 3-year-old child with coronary involvement and rash. The child was initially suspected of having atypical Kawasaki and was refractory to IVIG. Child had finally improved with pulse methylprednisolone after diagnosis was revised to be childhood PAN due to multiple intra-abdominal visceral vascular involvement. Table 1 summarizes the reported cases of PAN with coronary involvement, including ours.
Both PAN and Kawasaki disease can present with a febrile illness, and it is challenging to differentiate between the two entities, particularly in the absence of typical dermatological features. Such a presentation may pose a diagnostic and therapeutic dilemma as the treatment option differs. Kawasaki disease presents more acutely with predominant affection to coronary vasculature, while PAN presents as a more insidious disease with multisystem involvement, vascular ulcer, and aneurysms in the celiac, mesenteric axis, and renal arteries (Supplementary Fig. 4) [12, 13]. Delineating the two conditions is essential to optimize the therapeutic strategy; IVIG is the first treatment option for Kawasaki disease. While prolonged immunosuppression with cyclophosphamide/MMF with steroids in this type of disease presentation having features of both diseases as indicated in PAN [10, 14]. Table 2 summarizes the key clinical and laboratory differences which can help to manage such challenging cases.
Kawasaki disease is an overt immunological reaction to superantigens mediated by T cells leading to infiltrates and inflammatory cascade. In contrast, in PAN, there is a pre-existing genetic predisposition or parainfectious activation of CD 8 + T cells with macrophages leading to the destruction of the vessel wall [15, 16].
In both cases, initial immunomodulation was as per the recent guidelines for the management of Kawasaki disease. However, the initial management with IVIG might have been insufficient for the underlying PAN, and the unchecked inflammation might have resulted in giant coronary aneurysms in both cases. This proves the value of the early diagnosis of PAN, even in cases of the coronary aneurysm, without being biased towards a diagnosis of Kawasaki disease as coronary aneurysm is not a sine qua non for Kawasaki disease, particularly in cases with an unusually long course and persistently raised inflammatory markers like the index cases.
Conclusion
Coronary aneurysm, although a rare presentation of childhood PAN, can be a sole presenting feature and can mimic Kawasaki disease. However, prolonged course and persistently raised inflammatory markers can guide subsequent investigations like DSA for confirmatory diagnosis of PAN in such cases.
Availability of data and materials
Not applicable.
Code availability
Not applicable.
References
Zhu F, Ang JY (2021) 2021 update on the clinical management and diagnosis of Kawasaki disease. Curr Infect Dis Rep 23(3):3. https://doi.org/10.1007/s11908-021-00746-1
McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135(17):927–999. https://doi.org/10.1161/CIR.0000000000000484
Eleftheriou D, Dillon MJ, Tullus K, Marks SD, Pilkington CA, Roebuck DJ, Klein NJ, Brogan PA (2013) Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years. Arthritis Rheum 65(9):2476–2485. https://doi.org/10.1002/art.38024
Kawakami T (2012) A review of pediatric vasculitis with a focus on juvenile polyarteritis nodosa. Am J Clin Dermatol 13(6):389–398. https://doi.org/10.2165/11599660-000000000-00000
Forbess L, Bannykh S (2015) Polyarteritis nodosa. Rheum Dis Clin North Am 41(1):33–46. https://doi.org/10.1016/j.rdc.2014.09.005. (vii)
Schrader ML, Hochman JS, Bulkley BH (1985) The heart in polyarteritis nodosa: a clinicopathologic study. Am Heart J 109:1353–1359. https://doi.org/10.1016/0002-8703(85)90365-5
Ozen S, Paediatric Rheumatology International Trials Organisation (PRINTO) et al (2010) EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69(5):798–806. https://doi.org/10.1136/ard.2009.116657
Bowyer S, Mason WH, McCurdy DK, Takahashi M (1994) Polyarteritis nodosa with coronary aneurysms: the Kawasaki-PAN controversy revisited (letter). J Rheumatol 21:1585
Munro AR, Beasley SW, Pattemore PK, Fraser R (2003) Fatal late onset necrotising enterocolitis in a term infant: atypical Kawasaki disease or polyarteritis nodosa of infancy? J Paediatr Child Health 39:555–557. https://doi.org/10.1046/j.1440-1754.2003.00217.x
Canares TL, Wahezi DM, Farooqi KM, Pass RH, Ilowite NT (2012) Giant coronary artery aneurysms in juvenile polyarteritis nodosa: a case report. Pediatr Rheumatol 10:1–5. https://doi.org/10.1186/1546-0096-10-1
Yamazaki-Nakashimada MA, Espinosa-Lopez M, Hernandez-Bautista V, Espinosa-Padilla S, Espinosa-Rosales F (2006) Catastrophic Kawasaki disease or juvenile Polyarteritis nodosa? Semin Arthritis Rheum 35(6):349–354. https://doi.org/10.1016/j.semarthrit.2006.02.002
Jennette J (2003) The relationship of Kawasaki disease to other systemic vasculitides. Pediatr Res 53:158. https://doi.org/10.1203/00006450-200301000-00028
Khanna S, Garikapati K, Goh DSL et al (2021) Coronary artery vasculitis: a review of current literature. BMC Cardiovasc Disord 21:7. https://doi.org/10.1186/s12872-020-01813-6
Cohen RD, Conn DL, Ilstrup DM (1980) Clinical features, prognosis, and response to treatment in polyarteritis. Mayo Clin Proc 55(3):146–155
Takahashi K, Oharaseki T, Yokouchi Y (2014) Update on etio and immunopathogenesis of Kawasaki disease. Curr Opin Rheumatol 26(1):31–36. https://doi.org/10.1097/BOR.0000000000000010
Parada-Turska J, Turska M (2018) The changing face of medium-sized vasculitis. Wiad Lek 71(1 pt 1):64–72
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
SPM, SD: literature review and wrote initial draft. LP, MJ, PN, SG: reviewed the draft. NB: concept, design, and review of the draft. All authors approved the final version of the draft. All authors take full responsibility for the integrity, accuracy, and all aspects of the work.
Corresponding author
Ethics declarations
Conflict of interest
No conflict of interest among the authors.
Informed consent
Informed consent was obtained from the patients’ parents.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mohankumar, S.P., Das, S., Likitha, P. et al. Kawasaki disease or polyarteritis nodosa: coronary involvement, a diagnostic conundrum. Rheumatol Int 43, 2327–2331 (2023). https://doi.org/10.1007/s00296-023-05388-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-023-05388-1